BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 36407281)

  • 1.
    Fan Z; Tang P; Li C; Yang Q; Xu Y; Su C; Li L
    J Oral Microbiol; 2023; 15(1):2145729. PubMed ID: 36407281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusobacterium nucleatum: a commensal-turned pathogen.
    Han YW
    Curr Opin Microbiol; 2015 Feb; 23():141-7. PubMed ID: 25576662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of
    Pignatelli P; Nuccio F; Piattelli A; Curia MC
    Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Fusobacterium nucleatum harbored virulence gene fadA are associated with ulcerative colitis and clinical outcomes.
    Li DH; Li ZP; Yan Zhang ; Zhou GZ; Ren RR; Zhao HJ; Zhang NN; Li JF; Peng LH; Yang YS
    Microb Pathog; 2021 Aug; 157():104964. PubMed ID: 34022363
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ghosh A; Jaaback K; Boulton A; Wong-Brown M; Raymond S; Dutta P; Bowden NA; Ghosh A
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOX1/2 activation in human gingival fibroblasts by Fusobacterium nucleatum facilitates attachment of Porphyromonas gingivalis.
    Ahn SH; Song JE; Kim S; Cho SH; Lim YK; Kook JK; Kook MS; Lee TH
    Arch Microbiol; 2016 Aug; 198(6):573-83. PubMed ID: 27071620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum Alters Atherosclerosis Risk Factors and Enhances Inflammatory Markers with an Atheroprotective Immune Response in ApoE(null) Mice.
    Velsko IM; Chukkapalli SS; Rivera-Kweh MF; Chen H; Zheng D; Bhattacharyya I; Gangula PR; Lucas AR; Kesavalu L
    PLoS One; 2015; 10(6):e0129795. PubMed ID: 26079509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontopathogens
    Shi T; Wang J; Dong J; Hu P; Guo Q
    Pathogens; 2023 Aug; 12(9):. PubMed ID: 37764918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More Than Just a Periodontal Pathogen -the Research Progress on
    Chen Y; Huang Z; Tang Z; Huang Y; Huang M; Liu H; Ziebolz D; Schmalz G; Jia B; Zhao J
    Front Cell Infect Microbiol; 2022; 12():815318. PubMed ID: 35186795
    [No Abstract]   [Full Text] [Related]  

  • 10. Can metagenomics unravel the impact of oral bacteriome in human diseases?
    Chattopadhyay I; Lu W; Manikam R; Malarvili MB; Ambati RR; Gundamaraju R
    Biotechnol Genet Eng Rev; 2023 Apr; 39(1):85-117. PubMed ID: 35861776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the Role of Fusobacterium Nucleatum in the Pathogenesis in and Out the Mouth.
    Tefiku U; Popovska M; Cana A; Zendeli-Bedxeti L; Recica B; Spasovska-Gjorgovska A; Spasovski S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2020 Jun; 41(1):87-99. PubMed ID: 32573481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum and adverse pregnancy outcomes: Epidemiological and mechanistic evidence.
    Vander Haar EL; So J; Gyamfi-Bannerman C; Han YW
    Anaerobe; 2018 Apr; 50():55-59. PubMed ID: 29409815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium nucleatum and oral cancer: a critical review.
    McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
    BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA.
    Zhang Z; Liu S; Zhang S; Li Y; Shi X; Liu D; Pan Y
    J Periodontol; 2022 Apr; 93(4):515-525. PubMed ID: 34458990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the Fusobacterium nucleatum T18 adhesin activity mediating coaggregation with Porphyromonas gingivalis T22.
    Kinder SA; Holt SC
    J Bacteriol; 1993 Feb; 175(3):840-50. PubMed ID: 8380804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
    Kumar A; Thotakura PL; Tiwary BK; Krishna R
    BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Periodontal Pathogen
    Wu H; Qiu W; Zhu X; Li X; Xie Z; Carreras I; Dedeoglu A; Van Dyke T; Han YW; Karimbux N; Tu Q; Cheng L; Chen J
    Front Aging Neurosci; 2022; 14():912709. PubMed ID: 35813949
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Jung YJ; Jun HK; Choi BK
    J Oral Microbiol; 2017; 9(1):1320193. PubMed ID: 28748028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic Mechanisms of
    Groeger S; Zhou Y; Ruf S; Meyle J
    Front Oral Health; 2022; 3():831607. PubMed ID: 35478496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.